All In Biotech

Drug Trial Radar · NCT02286947

Safety Study of Eteplirsen to Treat Advanced Stage Duchenne Muscular Dystrophy

An Open-Label, Multi-Center Study to Evaluate the Safety and Tolerability of Eteplirsen in Patients With Advanced Stage Duchenne Muscular Dystrophy

Last checked: Nov 20, 2026Latest source record: Mar 30, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

24

Actual

Start

Nov 2014

Primary completion

Apr 21, 2017

Study completion Mar 23, 2018

Sponsor

Lead sponsor
Sarepta Therapeutics, Inc.Industry
Sponsor type
Industry
First posted
Nov 10, 2014

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
Male only, from 7 years, up to 21 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary objective of this study is to explore safety and tolerability of eteplirsen in participants with advanced stage Duchenne muscular dystrophy (DMD) who are amenable to exon 51 skipping.

Conditions

  • Muscular Dystrophy, Duchenne

Interventions

  • EteplirsenDrug

    Eteplirsen solution for IV infusion

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants With Treatment Emergent Adverse EventsTime frame: From first dose of drug up to 100 weeks

Locations

9 sites in 1 country. Site status is shown where the registry gives one.

  • Ronald Reagan UCLA Medical Center

    Los Angeles, California

  • University of California, Davis Medical Center

    Sacramento, California

  • University of Iowa Children's Hospital

    Iowa City, Iowa

  • Kennedy Krieger Institute

    Baltimore, Maryland

  • Massachusetts General Hospital

    Boston, Massachusetts

  • St. Louis Children's Hospital

    St Louis, Missouri

  • University of Rochester Medical Center

    Rochester, New York

  • Nationwide Children's Hospital

    Columbus, Ohio

  • Seattle Children's Hospital

    Seattle, Washington

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.